| 000 | 01663 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515052930.0 | ||
| 264 | 0 | _c20070130 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0008-5472 | ||
| 024 | 7 |
_a10.1158/0008-5472.CAN-06-1538 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSmalley, Keiran S M | |
| 245 | 0 | 0 |
_aAn organometallic protein kinase inhibitor pharmacologically activates p53 and induces apoptosis in human melanoma cells. _h[electronic resource] |
| 260 |
_bCancer research _cJan 2007 |
||
| 300 |
_a209-17 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 _xantagonists & inhibitors |
| 650 | 0 | 4 | _aGlycogen Synthase Kinase 3 beta |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMelanoma _xdrug therapy |
| 650 | 0 | 4 |
_aMitochondria _xdrug effects |
| 650 | 0 | 4 |
_aOrganometallic Compounds _xpharmacology |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aRuthenium _xchemistry |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xbiosynthesis |
| 650 | 0 | 4 | _aUp-Regulation |
| 700 | 1 | _aContractor, Rooha | |
| 700 | 1 | _aHaass, Nikolas K | |
| 700 | 1 | _aKulp, Angela N | |
| 700 | 1 | _aAtilla-Gokcumen, G Ekin | |
| 700 | 1 | _aWilliams, Douglas S | |
| 700 | 1 | _aBregman, Howard | |
| 700 | 1 | _aFlaherty, Keith T | |
| 700 | 1 | _aSoengas, Maria S | |
| 700 | 1 | _aMeggers, Eric | |
| 700 | 1 | _aHerlyn, Meenhard | |
| 773 | 0 |
_tCancer research _gvol. 67 _gno. 1 _gp. 209-17 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/0008-5472.CAN-06-1538 _zAvailable from publisher's website |
| 999 |
_c16776515 _d16776515 |
||